Concepedia

Author

C. Paul

Université Toulouse III - Paul SabatierORCID

Also Known As

, Paul, A.CARATY, Association, Francim, Bouquet, Y., C Paul, C. F. Paul, C. PAUL, C. Paul, C.F. Paul, CF Paul

904

Publications

28.4K

Citations

89

H-Index

191

Concepts

All Affiliations

Université Toulouse III - Paul SabatierHôpital LarreyInsermUniversité Fédérale de Toulouse Midi-PyrénéesNovartis (Switzerland)
CP

About

C. Paul is an author at Université Toulouse III - Paul Sabatier specializing in medicine, dermatology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

37

68

7.7K

2

Engineering

2

2

184

3

Health Sciences

2

2

23

4

Arts

1

1

388

5

Law

1

1

29

C. Paul

×

242

Publications

21K

Citations

76

H-Index

YearCitations

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

C.E.M. Griffiths, Kristian Reich, Mark Lebwohl,

The Lancet

2015

815

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

Mark Lebwohl, Bruce Strober, Alan Menter,

New England Journal of Medicine

2015

790

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni,

The Lancet

2017

586

Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

Mark Lebwohl, H. Bachelez, Giampiero Girolomoni,

Journal of the American Academy of Dermatology

2014

505

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)

C. Paul, Jennifer Clay Cather, Melinda Gooderham,

British Journal of Dermatology

2015

464

A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

Kim Papp, Kristian Reich, C. Paul,

British Journal of Dermatology

2016

449

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Andreas Wollenberg, Stéphanie Christen-Zäch, C. Paul,

Journal of the European Academy of Dermatology and Venereology

2020

445

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg,

New England Journal of Medicine

2021

419

Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of Atopic Dermatitis in Children

Ulrich Wahn, Jan D. Bos, Mark Goodfield,

PEDIATRICS

2002

402

European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – <scp>EDF</scp> in cooperation with <scp>EADV</scp> and <scp>IPC</scp>

Alexander Nast, Paolo Gisondi, Anthony D. Ormerod,

Journal of the European Academy of Dermatology and Venereology

2015

388

Page 1